AGORA Cancer Research Center
AGORA was inspired by the vision that the integration of progress in cancer research into clinical practice can be accelerated by bringing together interdisciplinary research teams of clinicians, cancer biologists, immunologists, bio-informaticians and bio-engineers. Initiated by the ISREC Foundation in 2013, the AGORA building was opened in 2018. The functioning of this translational cancer research center reflects a partnership between the Lausanne University Hospital (CHUV), the University of Lausanne (UNIL), the Swiss Federal Institute of Technology of Lausanne (EPFL), the University Hospitals of Geneva (HUG) and the University of Geneva (UNIGE).
Latest news
Events
Swiss Myeloid League (SMyLe) monthly Seminar series | July 14th
Events
Oncology Grand Rounds, Prof. John Haanen | August 21st
Events
EPFL Latsis Symposium 2026 | October 29-30
Events
Join AGORA PhD & Postdoc Association
Latest publications
A gold-standard French-language annotated corpus of oncological entities with ICD-O normalisation.
Pignat J, Vucetic M, Gaudet-Blavignac C, (…), Michielin O, Lovis C, Bjelogrlic M
Scientific data – 2026 Jun 30
Imaging the hallmarks of cancer.
Grimm J, Kiessling F, Brindle KM, (…), Weber WA, Weigelin B, Pichler BJ
Nature reviews. Cancer – 2026 Jun 29
Precision medicine’s inevitable trajectory toward rare-disease-sized cohorts: implications for machine learning and deep learning.
Janowczyk A, Merkler D, Michielin O, Madabhushi A
The Lancet. Digital health – 2026 Jun 15
Expert opinion on burning questions in cancer myeloid cell biology.
Guerriero JL, Merad M, Ginhoux F, (…), Barry ST, Varner JA, Gabrilovich DI
Journal for immunotherapy of cancer – 2026 Jun 3
Tumor-targeted interferon-α gene therapy for glioblastoma: a phase 1 trial.
Gentner B, Eoli M, Farina F, (…), Russo C, Ciceri F, Naldini L
Nature medicine – 2026 Jun 1